Jefferies lifts Tenet Healthcare [THC] rating to Buy and price target to $60
Jefferies took its Tenet Healthcare [THC] rating to the equivalent of Buy from Hold, and the price target to $60.0 from $18.5, in a research note dated 2021-01-08. That figure represents around a 34.02% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Deutsche Bank’s analysts upgrading the […]
